Archive:Venalex: Difference between revisions
better phrasing |
→Therapeutic indications: more specificity |
||
| Line 7: | Line 7: | ||
== Therapeutic indications== | == Therapeutic indications== | ||
Venalex is used to treat chronic functional or structural [[Chronic venous insufficiency|venous insufficiency]] of the lower limbs. [[Lymphedema]]. | Venalex is used to treat chronic functional or structural [[Chronic venous insufficiency|venous insufficiency]] of the lower limbs. [[Lymphedema]]. It is also used for treatment of hemorrhoids and ailments caused by pressure ulcers. No results of clinical trials have been published. Venalax is not approved by the FDA. | ||
== Dosage == | == Dosage == | ||
Revision as of 22:04, 19 October 2023
Template:Multiple issues Venalex is a micronized purified flavonoid fraction containing 90% diosmin and 10% hesperidin.
Therapeutic indications
Venalex is used to treat chronic functional or structural venous insufficiency of the lower limbs. Lymphedema. It is also used for treatment of hemorrhoids and ailments caused by pressure ulcers. No results of clinical trials have been published. Venalax is not approved by the FDA.
Dosage
2 capsules per day. Do not exceed the recommended daily dose. Nutritional supplement cannot substitute for a healthy, balanced diet.
Additional information
Venalex is usually very well tolerated by the body and very rare side effects associated with its use.